Abstract
We evaluated the hypothesis that an increase in the hydrogen sulfide concentration in pulmonary artery smooth muscle cells causes hypoxic pulmonary vasoconstriction (HPV) by examining the effects of the sulfide donor cysteine and sulfide-synthesis blockers on HPV in isolated rat intrapulmonary arteries (IPA).
Cysteine (1 mM) enhanced HPV and also the contraction to PGF2 and both effects were abolished by the cystathionine lyase blocker propargylglycine (PAG, 1 mM), which had little or no non-selective effect on contraction at this concentration. Neither PAG nor the cysteine aminotransferase antagonist aspartate affected HPV in normal PSS, or in PSS containing physiological concentrations of cysteine, cystine and glutamate, whereas dithiothreitol (DTT), proposed to enhance HPV by converting mitochondrial thiosulfate to sulfide, instead abolished HPV. PAG markedly diminished whereas DTT did not affect cysteine-induced sulfide release from liver pieces.
The results do not support the proposal that hydrogen sulfide plays a role in HPV.
Cysteine (1 mM) enhanced HPV and also the contraction to PGF2 and both effects were abolished by the cystathionine lyase blocker propargylglycine (PAG, 1 mM), which had little or no non-selective effect on contraction at this concentration. Neither PAG nor the cysteine aminotransferase antagonist aspartate affected HPV in normal PSS, or in PSS containing physiological concentrations of cysteine, cystine and glutamate, whereas dithiothreitol (DTT), proposed to enhance HPV by converting mitochondrial thiosulfate to sulfide, instead abolished HPV. PAG markedly diminished whereas DTT did not affect cysteine-induced sulfide release from liver pieces.
The results do not support the proposal that hydrogen sulfide plays a role in HPV.
Original language | English |
---|---|
Pages (from-to) | 385-401 |
Journal | The Journal of Physiology |
Volume | 593 |
Issue number | 2 |
Early online date | 6 Nov 2014 |
DOIs | |
Publication status | Published - 15 Jan 2015 |
Keywords
- hypoxic pulmonary vasoconstriction
- sulphide